Your browser doesn't support javascript.
loading
Modern Techniques in Re-Irradiation for Locally Recurrent Rectal Cancer: A Systematic Review.
Mantello, Giovanna; Galofaro, Elena; Bisello, Silvia; Chiloiro, Giuditta; Romano, Angela; Caravatta, Luciana; Gambacorta, Maria Antonietta.
Afiliação
  • Mantello G; Radiotherapy Department, Azienda Ospedaliero Universitaria delle Marche, 60126 Ancona, Italy.
  • Galofaro E; Radiotherapy Department, Azienda Ospedaliero Universitaria delle Marche, 60126 Ancona, Italy.
  • Bisello S; Radiotherapy Department, Azienda Ospedaliero Universitaria delle Marche, 60126 Ancona, Italy.
  • Chiloiro G; Departments of Radiation Oncology, Fondazione Policlinico Universitario A.Gemelli IRCCS, 00168 Roma, Italy.
  • Romano A; Departments of Radiation Oncology, Fondazione Policlinico Universitario A.Gemelli IRCCS, 00168 Roma, Italy.
  • Caravatta L; Department of Radiation Oncology, SS Annunziata Hospital, 66100 Chieti, Italy.
  • Gambacorta MA; Departments of Radiation Oncology, Fondazione Policlinico Universitario A.Gemelli IRCCS, 00168 Roma, Italy.
Cancers (Basel) ; 15(19)2023 Oct 03.
Article em En | MEDLINE | ID: mdl-37835532
BACKGROUND: Radiotherapy (RT) plays an important role in the treatment of patients with previously irradiated locally recurrent rectal cancer (LRRC). Over the years, numerous technologies and different types of RT have emerged. The aim of our systematic literature review was to determine whether the new techniques have led to improvements in both outcomes and toxicities. METHODS: A computerized search was performed by MEDLINE and the Cochrane database. The studies reported data from patients treated with carbon ion radiotherapy (CIRT), intensity-modulated photon radiotherapy (IMRT), and stereotactic radiotherapy (SBRT). RESULTS: Seven publications of the 126 titles/abstracts that emerged from our search met the inclusion criteria and presented outcomes of 230 patients. OS was reported with rates of 90.0% and 73.0% at 1 and 2 years, respectively; LC was 89.0% and 71.6% at 1 and 2 years after re-RT, respectively. Toxicity data vary widely, with emphasis on acute and chronic gastrointestinal and urogenital toxicity, even with modern techniques. CONCLUSION: data on toxicity and outcomes of re-RT for LRRC with new technologies are promising compared with 3D techniques. Comparative studies are needed to define the best technique, also in relation to the site of recurrence.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article